Rosana Kapeller, M.D., Ph.D.
Rosana Kapeller is the co-founder, CEO and president of ROME Therapeutics and a fellow at GV (formerly Google Ventures), focused on the intersection of therapeutics and machine learning. In her former role as the founding CSO at Nimbus Therapeutics, Rosana led the company’s drive to apply advanced computational technologies to the design and development of novel therapeutics. In her eight years at Nimbus, she assembled a strong scientific team that validated the company’s platform and advanced multiple promising programs. Before joining Nimbus, Rosana worked as vice president of research at Aileron Therapeutics. She started her career as a scientist at Millennium Pharmaceuticals, where she advanced through positions of increasing responsibility to director. Rosana has served as an adviser to Atlas Venture and has a consultant to Third Rock Ventures. She holds a Ph.D. in molecular and cellular physiology from Tufts University and a M.D. from Universidade do Estado do Rio de Janeiro in Brazil.